To overcome this limitation, we used previously a bispecific antibody (BAb) directed against carcinoembryonic antigen (CEA) and TNFα to target this cytokine in human CEA-expressing colorectal carcinoma treated simultaneously with RT (Azria et al, 2003a). Here, CEACAM5 is linked to colorectal carcinoma.